Clinical Trial Update: Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients [Phase 3]

View source ↗

Summary

This Phase 3 trial evaluated renal function after reducing the dose of cyclosporine A in renal transplant recipients and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease
• Renal Transplant Rejection

Drugs mentioned

• Cyclosporine A (cyclosporine)

Snippet

Sponsor: University Hospital, Rouen | Conditions: Kidney Transplantation, Primary Prevention | Phase 3 | Status: COMPLETED